KARLA DOUGLAS: Open Payments
NPI 1114652203 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 32 payments from 11 companies in 2025. Trend: 2023 $611 · 2024 $1,047 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 8 | $366 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $88 |
| Stryker Corporation | 2 | $45 |
| Alnylam Pharmaceuticals Inc. | 2 | $30 |
| Kestra Medical Technology Services, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
| Inari Medical, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: LifeVest, Kerendia, FLOWTRIEVER CATHETER, S, AMVUTTRA, Assure WCD, Wegovy, ZEPBOUND, FARXIGA.
Industry payments across LA — which companies pay providers there.
